1. Home
  2. POOL vs RGEN Comparison

POOL vs RGEN Comparison

Compare POOL & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pool Corporation

POOL

Pool Corporation

N/A

Current Price

$211.45

Market Cap

9.5B

ML Signal

N/A

Logo Repligen Corporation

RGEN

Repligen Corporation

N/A

Current Price

$119.94

Market Cap

8.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
POOL
RGEN
Founded
1993
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.5B
8.1B
IPO Year
1997
1995

Fundamental Metrics

Financial Performance
Metric
POOL
RGEN
Price
$211.45
$119.94
Analyst Decision
Buy
Buy
Analyst Count
10
11
Target Price
$292.29
$173.09
AVG Volume (30 Days)
873.7K
771.2K
Earning Date
05-22-2026
05-27-2026
Dividend Yield
2.39%
N/A
EPS Growth
N/A
286.96
EPS
10.85
0.86
Revenue
$5,289,396,000.00
$141,236,000.00
Revenue This Year
$4.51
$14.11
Revenue Next Year
$3.98
$14.71
P/E Ratio
$19.25
$141.40
Revenue Growth
N/A
35.10
52 Week Low
$204.16
$102.97
52 Week High
$345.00
$175.77

Technical Indicators

Market Signals
Indicator
POOL
RGEN
Relative Strength Index (RSI) 31.34 32.30
Support Level $210.67 $113.07
Resistance Level $227.80 $132.51
Average True Range (ATR) 7.45 6.52
MACD -1.25 -0.11
Stochastic Oscillator 30.16 6.37

Price Performance

Historical Comparison
POOL
RGEN

About POOL Pool Corporation

Pool Corp distributes swimming pool supplies and related products. Its products include non-discretionary pool-maintenance products, like chemicals and replacement parts, as well as pool equipment, like packaged pools (kits to build swimming pools), cleaners, filters, heaters, pumps, and lights. Customers include pool builders and remodelers, independent retail stores, and pool repair and service companies.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: